Notably, NER activity was significantly higher in KRAS-mutant NSCLC cells compared with KRAS WT lung cancer cells (Supplemental Figure 5, E and F), suggesting a positive correlation between KRAS mutations and NER activity in NSCLC cells. The gene discussed is KRAS; the disease is lung carcinoma.